Global AblationDevices Market, by Technology Type (Radiofrequency Ablation, MicrowaveAblation, Cryoablation, High-Intensity Focused Ultrasound, Laser InterstitialThermal Ablation, and Others), by Application (Cancer, Ophthalmology, Urology,Gynaecology, Cardiovascular, andOrthopedic), by Function (Automatic and Robotic), by Procedure (Tumor Ablation,Varicose Veins, Atrial Fibrillation, Aesthetics- Skin Rejuvenation andTightening, Laser and Other Energy Based Therapies), by End User (Hospitals,Ambulatory Surgical Centers, and Specialty), and by Region (North America,Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued atUS$ 4,290.82 million in 2019 and isexpected to exhibit a CAGR of 10.9% over the forecast period (2019-2027).
Increasing acquisitions, mergersand collaborations by key players is expected to drive the global ablationdevices market growth during the forecast period. For instance in 2016, BostonScientific Corporation, acquired Cosman Medical, Inc., a manufacturer ofradiofrequency ablation (RFA) systems. This acquisition has further expandedBoston Scientific’s Spinal Cord Stimulator and Deep Brain Stimulation Systemsportfolio. Furthermore, in 2015, EDAP TMS announced a multinational strategicOEM partnership with Quanta System, a leading manufacturer of medical lasersfor surgical applications. Through this partnership, Quanta manufacturescustomized urological stone lasers to be sold under the EDAP brand.Additionally, in 2013, Abbott Laboratories acquired IDEV Technologies, aprivately-owned company focused on developing next-generation medical devicesfor use of ablation catheters in electrophysiology.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/464
The company also acquired twoother catheter-based medical device companies, namely Advanced CardiacTherapeutics, Inc. and Topera, Inc., in order to enter the electrophysiologyablation devices market.
Browse 52 Market Data Tables and48 Figures spread through 305 Pages and in-depth TOC on "Global AblationDevices Market, by Technology Type (Radiofrequency Ablation, MicrowaveAblation, Cryoablation, High-Intensity Focused Ultrasound, Laser InterstitialThermal Ablation, and Others), by Application (Cancer, Ophthalmology, Urology,Gynaecology, Cardiovascular, andOrthopedic), by Function (Automatic and Robotic), by Procedure (Tumor Ablation,Varicose Veins, Atrial Fibrillation, Aesthetics- Skin Rejuvenation and Tightening,Laser and Other Energy Based Therapies), by End User (Hospitals, AmbulatorySurgical Centers, and Specialty), and by Region (North America, Latin America,Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2027"
he global ablation devices marketis expected to witness significant growth over the forecast period, owing toincreasing regulatory approval for ablation Devices, For instance, in April2019, Innoblative Designs, Inc., received U.S. Food and Drug Administration(FDA) clearance for its SIRA RFA Electrosurgical Device, a novel radiofrequencyablation (RFA) applicator for electrosurgery.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/ablation-devices-market-464
Key Takeaways of the GlobalAblation Devices Market:
The global ablation devicesmarket expected to exhibit a CAGR of 10.9% over the forecast period(2019–2027), owing to increasing acquisition, merger and collaborationactivities by key player.
Among technology type, theradiofrequency ablation segment is expected to account for a major revenueshare by 2027, owing to increasing launches of radiofrequency ablation systems.For instance, in February 2019, Medtronic Plc. Launched Accurian Radiofrequencyablation system in the U.S. for nerve tissue ablation and also received 510(k)clearance from the US Food and Drug Administration (FDA).
Major players operating in theglobal ablation devices market include Arthrex, Boston Scientific Corporation,Medtronic Plc, Intuitive Surgical, Inc., Johnson & Johnson, Inc., HalyardHealth, Abbott Laboratories, EDAP TMS S.A., AtriCure, Inc., and Smith &Nephew.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/464
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
